Monaco Commerce Press
SEE OTHER BRANDS

Hottest business and economy news from Monaco

Holzer & Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against LifeMD, Inc. (LFMD), Semler Scientific, Inc. (SMLR) and Quantum Corp. (QMCO)

ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits:

LifeMD, Inc. (LFMD)

The shareholder class action lawsuit filed against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts concerning LifeMD’s competitive position between May 7, 2025 and August 5, 2025. If you purchased LifeMD shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/lifemd/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is October 27, 2025.

Semler Scientific, Inc. (SMLR)

The shareholder class action lawsuit filed against Semler Scientific, Inc. (“Semler Scientific” or the “Company”) (NASDAQ: SMLR) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts regarding the United States Department of Justice’s investigation into violations of the False Claims Act between March 10, 2021 and April 15, 2025. If you purchased Semler Scientific shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/semler-scientific/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is October 28, 2025.

Quantum Corp. (QMCO)

The shareholder class action lawsuit filed against Quantum Corporation (“Quantum” or the “Company”) (NASDAQ: QMCO) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts regarding improperly recognized revenue during the fiscal year ended March 31, 2025, between November 15, 2024, and August 18, 2025. If you purchased Quantum shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/quantum/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is November 3, 2025.

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, https://holzerlaw.com/, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.

CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions